Lexaria Bioscience (LEXX) Stock Analysis: AI Score & Alternative Data
Lexaria Bioscience — alt-data steady across 90 days
Is Lexaria Bioscience a buy right now? The alternative data says hold. This LEXX stock analysis is built on the 25+ alternative data signals AltIndex tracks on Lexaria Bioscience every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 43/100: a Hold. The stock trades at $3.32 with a $7M market cap.
No core signal has moved more than 5% in 90 days — steady, but without the momentum that pushes a stock into buy territory.
LEXX’s broader alt-data profile also covers headcount (10 employees, according to LinkedIn), web traffic (2K monthly visits), Facebook followers (2K), and sentiment (100/100). Every signal links to its own page with full history, the LEXX technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on LEXX is just below.
Lexaria Bioscience AI Stock Analysis
Lexaria Bioscience is an innovative biotechnology company that focuses on the development of novel drug delivery systems, primarily through their proprietary DehydraTECH™ technology. This technology aims to improve the speed and efficiency of drug delivery, primarily for cannabinoids, nicotine, and other bioactive molecules.
Analysis generated October 1, 2026.
Recent Lexaria Bioscience Stock Alerts
|
Lexaria Bioscience | October 9 Price is up by 7.5% in the last 24h. |
|
Lexaria Bioscience | October 8 Price is down by -7.2% in the last 24h. |
|
Lexaria Bioscience | October 7 Price is up by 6% in the last 24h. |
|
Lexaria Bioscience | October 6 Price is up by 6.1% in the last 24h. |
Lexaria Bioscience Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 2K | 4.0% | |
| Job Posts | 0 | N/A | |
| LinkedIn Employees | 10 | 0% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 17 | 1,600.0% | |
| Stocktwits Mentions | 45 | 22.4% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 3K | 0% | |
| X Followers | 867 | 1.1% | |
| Facebook Followers | 2K | 0% | |
| Facebook Engagement | 0 | N/A |
About Lexaria Bioscience (LEXX)
Lexaria Bioscience Corp. The company is headquartered in Kelowna, Canada.
| Price | $3.32 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $7M |
| Year Range | $3 – $20 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Lexaria Bioscience News
View more →
Wellstar Technologies initiated with bullish view at Stifel, here's whyOctober 2 - Thefly.com |
|
Whoosh Wellness Launches Physician-Guided Telehealth Platform Offering Oral-First Wellness Protocols and Prescribed Microdosing ProgramsJune 5 - GlobeNewswire |
|
See Lexaria Bioscience’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for LEXX, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREELexaria Bioscience Earnings & Financial Performance
View all earnings →Lexaria Bioscience Insider Trading Activity
View all →| BUNKA CHRISTOPHER filed to sell 281,912 shares at $0.0. Jul 30 '25 |
| Carle Vanessa filed to sell 750 shares at $0.0. Jul 29 '25 |
| DOCHERTY JOHN MARTIN filed to sell 5,376 shares at $0.0. Jul 29 '25 |
| McKechnie William Edward filed to sell 18,191 shares at $0.0. Jul 29 '25 |
| CHRISTOPHER RICHARD filed to sell 65,000 shares at $0.0. Jul 29 '25 |
Lexaria Bioscience Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Lexaria Bioscience
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
ExicureXCUR |
$1.05 5.0% | $7M | 40 |
 |
AIM ImmunoTechAIM |
$0.18 0.2% | $7M | 63 |
 |
NeuroSense TherapeuticsNRSN |
$3.66 2.2% | $7M | 44 |
 |
CollPlant BiotechnologiesCLGN |
$3.51 11.6% | $7M | 41 |
 |
Reviva PharmaceuticalsRVPH |
$0.50 1.0% | $7M | 46 |
Explore Lexaria Bioscience Data
Frequently Asked Questions: Lexaria Bioscience (LEXX)
Lexaria Bioscience has an AltIndex AI Score of 43/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
43/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Lexaria Bioscience (LEXX) stock is $3.32 with a market cap of $7M.
As of today, Lexaria Bioscience’s PE (Price to Earnings) ratio is —.
View the latest Lexaria Bioscience insider transactions to see recent buying and selling activity by company executives and directors.
Check the Lexaria Bioscience congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The LEXX stock price chart above shows Lexaria Bioscience’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Lexaria Bioscience technical analysis for RSI, moving averages, and more.
See the stocks similar to Lexaria Bioscience section on this page for companies in the same industry ranked by market cap and AI Score.
